SCHEMBL6980588

SCHEMBL6980588

CC(C)CC(C(=O)O)[C@@H](CCNC(=O)c1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
EPHX2 P34913 1/20 0.46
KCNA5 P22460 2/20 0.42
KDM4E B2RXH2 1/20 0.42
PKM P14618 1/20 0.42
ESRRG P62508 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
POLB P06746 2/20 0.41
LMNA P02545 1/20 0.41
PRSS1 P07477 2/20 0.40
CTSG P08311 2/20 0.40
CTRB1 P17538 2/20 0.40
CMA1 P23946 2/20 0.40
HPGD P15428 1/20 0.40
NR1H2 P55055 1/20 0.40
AAK1 Q2M2I8 1/20 0.40
CASP3 P42574 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980590 1.00 NPC1 (0.48) NPC1RAB9ASMN1; SMN2EPHX2KCNA5
SCHEMBL7955175 0.88 KMT2A (0.43) NPC1RAB9ASMN1; SMN2KDM4EPKM
SCHEMBL27508603 0.88 KMT2A (0.43) NPC1RAB9ASMN1; SMN2KDM4EPKM
SCHEMBL6981775 0.88 KMT2A (0.43) NPC1RAB9ASMN1; SMN2KDM4EPKM
SCHEMBL6983142 0.86 NPC1 (0.42) NPC1RAB9ASMN1; SMN2EPHX2KCNA5
SCHEMBL7836648 0.77 MAPT (0.40) NPC1RAB9ASMN1; SMN2KDM4EPKM
SCHEMBL7955112 0.77 MAPT (0.40) NPC1RAB9ASMN1; SMN2KDM4EPKM
SCHEMBL6943292 0.77 MMP3 (0.45) PKMMEN1KMT2APOLBLMNA
SCHEMBL6943287 0.77 MMP3 (0.45) PKMMEN1KMT2APOLBLMNA
SCHEMBL6659520 0.77 MMP3 (0.45) PKMMEN1KMT2APOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed